A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization

Area of Science:

• Immunology
• Cell Biology

Background:

• Leukocytes play a crucial role in immune responses, including directed migration (chemotaxis).
• Dysregulation of leukocyte chemotaxis is implicated in various inflammatory and immune disorders.

Purpose of the Study:

• To identify and characterize a factor derived from human leukocytes that modulates neutrophil chemotaxis.
• To investigate the properties and release mechanisms of this novel inhibitory factor.

Main Methods:

• Isolation and partial purification of the factor from human leukocyte cultures.
• Assays to evaluate the effect of the factor on neutrophil and monocyte chemotaxis.
• Determination of molecular weight and sensitivity to enzymatic digestion (trypsin, chymotrypsin).

Main Results:

• A factor was derived from human leukocytes that irreversibly inhibits neutrophil chemotaxis to various stimuli.
• The factor is released under specific conditions (acidic medium, endotoxin exposure, phagocytosis) and is preformed.
• The neutrophil-immobilizing factor has a molecular weight of 5000 and is inactivated by proteases, suggesting a protein nature.
• The factor primarily affects neutrophils with minimal impact on monocyte chemotaxis.

Conclusions:

• A novel neutrophil-immobilizing factor (NIF) derived from human leukocytes directly inhibits neutrophil migration.
• NIF is released by both polymorphonuclear and mononuclear leukocytes and is preformed within these cells.
• The characterization of NIF provides insights into the regulation of leukocyte migration and potential therapeutic targets in inflammatory diseases.